The District Hospital's Deferred Maintenance Squeeze
A district hospital operates under a rigid line-item budget approved mid-year by the local council. Its annual allocation is Tk 180 million, of which Tk 120 million is locked into salaries and utilities. The remaining Tk 60 million covers medicines, maintenance, and minor capital. During the year, an outbreak raises medicine consumption by 35%. The hospital's chief executive wants to move Tk 15 million from a dormant 'equipment upgrade' line to medicines. The finance officer warns that re-appropriation above 10% of a line requires council approval, which meets only quarterly. Meanwhile, two ambulances are grounded for want of Tk 3 million in spare parts, and staff overtime of Tk 8 million is unpaid. A donor has offered Tk 20 million, but only for new construction, not recurrent costs.
1. Advise the chief executive on how to finance the medicine shortfall within the next six weeks without breaching the budget framework.
Read the worked answer
The medicine gap is roughly Tk 21 million (35% of the Tk 60 million flexible envelope). The chief executive cannot simply re-appropriate Tk 15 million because that exceeds the 10% line threshold and needs council approval. The practical sequence is:
- Quantify and prioritise. Separate essential medicines from discretionary stock, and compute the true six-week cash need rather than the annualised 35% figure. Some of the increase may be timing, not permanent.
- Use lawful virement within limits. Re-appropriate up to 10% of each eligible line without council approval, aggregating small movements across several lines.
- Escalate the rest to the council with a written supplementary estimate, requesting an emergency or out-of-session decision. Present it as a public-health risk, not a bookkeeping request.
- Defer non-urgent commitments such as the equipment upgrade, and release the Tk 3 million for ambulance parts only if it prevents service collapse.
- Negotiate with the donor to convert part of the Tk 20 million into recurrent support or to fund a medicine buffer stock under a health-systems heading.
- Address the Tk 8 million overtime separately, since unpaid wages create legal and morale risk.
The core judgement is that rigid line-item control protects probity but harms allocative efficiency; the executive should use every lawful flexibility first, then seek transparent political authorisation rather than informal overspending.
2. The finance officer proposes carrying the medicine overspend into next year's budget as a 'pending liability'. Evaluate this proposal.
Read the worked answer
Carrying the overspend as a 'pending liability' is not a neutral timing device; it is an undeclared deficit. The evaluation should weigh three dimensions.
Accounting and transparency. Under cash or modified-cash budgeting, an incurred but unpaid obligation is still a commitment. Recording it as 'pending' outside the approved estimate conceals the true fiscal position from the council and auditors. It should be disclosed as arrears, with a clear ageing schedule.
Legal authority. Spending beyond an appropriation without authorisation is generally unlawful, even if the supplier is paid later. The officer's proposal risks converting a cash-flow problem into a compliance breach.
Sustainability. Rolling the liability forward assumes next year's budget has slack. If next year is equally tight, the arrears compound and crowd out future medicines, creating a spiral.
A better alternative is to seek a supplementary appropriation now, present a realistic arrears schedule, and build a contingency reserve for outbreaks. If carry-forward is permitted by the finance rules, it must be explicitly authorised, disclosed, and matched by a financing plan, not merely labelled 'pending'.